Semler Scientific forms new subsidiary CardioVanta for heart disease detection and monitoring

Semler Scientific, Inc.

Semler Scientific formed CardioVanta, a wholly-owned subsidiary focused on heart failure detection and cardiac arrhythmia monitoring.
CardioVanta will seek outside investment to validate its long-term value and fund its initial capital needs.
No financial details or operational timeline for the subsidiary were disclosed.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.